Margaret J. McElrath
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Molecular Biology, Microbiology Biology, ImmunologyGoogle:
"Margaret McElrath"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lemos MP, Lazarus E, Isaacs A, et al. (2019) Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915). Journal of Acquired Immune Deficiency Syndromes (1999). 81: e39-e48 |
| Rademeyer C, Korber B, Seaman MS, et al. (2016) Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. Plos Pathogens. 12: e1005742 |
| Slichter CK, McDavid A, Miller HW, et al. (2016) Distinct activation thresholds of human conventional and innate-like memory T cells. Jci Insight. 1 |
| Hughes SM, Shu Z, Levy CN, et al. (2016) Cryopreservation of Human Mucosal Leukocytes. Plos One. 11: e0156293 |
| Schoofs T, Klein F, Braunschweig M, et al. (2016) HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1. Science (New York, N.Y.). 352: 997-1001 |
| Tjernlund A, Burgener A, Lindvall JM, et al. (2016) In Situ Staining and Laser Capture Microdissection of Lymph Node Residing SIV Gag-Specific CD8+ T cells-A Tool to Interrogate a Functional Immune Response Ex Vivo. Plos One. 11: e0149907 |
| Havenar-Daughton C, Lindqvist M, Heit A, et al. (2016) CXCL13 is a plasma biomarker of germinal center activity. Proceedings of the National Academy of Sciences of the United States of America |
| Baden LR, Karita E, Mutua G, et al. (2016) Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. Annals of Internal Medicine |
| Pattacini L, Baeten JM, Thomas KK, et al. (2015) Regulatory T-cell activity but not conventional HIV-specific T-cell responses are associated with protection from HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999) |
| Fuchs JD, Bart PA, Frahm N, et al. (2015) Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. Journal of Aids & Clinical Research. 6 |